EOLS

Evolus, Inc. is a healthcare company that operates in the drug manufacturers - specialty & generic industry. The company has a market capitalization of $392.16 million and employs 329 individuals. Evolus' revenue for the trailing twelve months (TTM) was $285.82 million. The company's financial health reveals several challenges. Evolus reported net income of -$58,562,000 for the TTM period, with an operating margin of -14.7% and a profit margin of -20.5%. Additionally, the return on assets (ROA) was -10.6%, indicating that the company is generating losses from its operations. The balance sheet shows cash of $43.52 million and debt of $154.89 million. Evolus' valuation metrics indicate a complex picture. The forward P/E ratio is 48.02, while the price to sales ratio is 1.37. The revenue growth rate for the year-over-year (YoY) period was 12.9%. Notably, Evolus does not pay dividends, as indicated by the payout ratio of 0.0%.